Comparative assessment of hepatoprotective effects of various liposome formulations in experimental venous congestion-induced chronic liver insufficiency
https://doi.org/10.20538/1682-0363-2012-4-130-135
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
The aim of the study was to evaluate the efficacy of lecithin/cholesterol liposomes in the therapy of experimental venous congestion-induced chronic liver insufficiency. The effects of the empty liposomes, ATP and phosphocreatine-containing liposomes and alpha-tocopherol and superoxide dismutase-containing liposomes were studied. It was found that liposomal drugs have a hepatoprotective effect, i.e. they decrease blood enzyme activity (cytolysis markers), reduce oxidative stress and preserve histologic integrity of the liver.
About the Authors
R. A. MukhamadiyarovRussian Federation
N. L. Vorontsova
V. V. Borisov
Yu. A. Kudryavtseva
I. Yu. Juravleva
References
1. Barsukov L.I. Liposomy // Sorosovskii obrazovatel'nyi zhurnal. 1998. № 10. S. 3-9.
2. Bilenko M.V. Ishemicheskie i reperfuzionnye povrezhdeniya organov. M.: Meditsina, 1989. 368 s.
3. Boyarinov G.A., Sokolov V.V. Ozonirovannoe iskusstvennoe krovoobrashchenie. N. Novgorod: Pokrovka, 1999. 318 s.
4. Vorontsova N.L., Mukhamadiyarov R.A., Zhuravleva I.Yu. Modelirovanie zastoinoi pechenochnoi nedostatochnosti v eksperimente na krysakh // Vestn. med. stomatol. in-ta [V pechati].
5. Ipatova O.M. Fosfogliv: mekhanizm deistviya i primenenie v klinike. M.: GU NII biomedkhim. RAMN, 2005. 318 s.
6. Margolis L.B., Bergel'son L.D. Liposomy i ikh vzaimodeistvie s kletkami. M.: Nauka, 1986. 240 s.
7. Promyslov M.Sh., Demchuk M.D. Modifikatsiya metoda
8. opredeleniya summarnoi antioksidantnoi aktivnosti syvorotki krovi // Vopr. med. khimii. 1990. № 4. S. 90-92.
9. Seifulla R.D. Farmakologiya liposomal'nykh prepratov. M.: Globus Kontinental', 2010. 242 s.
10. Sergeeva G.I., Knyaz'kova L.G., Mogutnova T.A. i dr. Ostrofazovyi otvet i biotransformatsionnaya aktivnost' pecheni posle operatsii na otkrytom serdtse // Patologiya krovoobrashcheniya i kardiokhirurgiya. 2006. № 1. C. 31-35.
11. Stal'naya I.D., Garishvili T.G. Metod opredeleniya malonovogo dial'degida s tiobarbiturovoi kislotoi // Sovremennye metody v biokhimii / pod red. Orekhovicha. M.: Meditsina, 1977. S. 66-67.
12. Abraldes J.G., Pasarín M., Pagán J.C.G. Animal models of portal hypertension // World J. Gastroenterol. 2006. V. 41, № 12. P. 6577-6584.
13. Aebi H. Catalase in vitro // Meth. Enzymol. 1984. V. 105. P. 121-126.
14. Allen T.M. Pharmacokinetics and biopharmaceutics of lipid-based drug formulations // Liposome Technology. V. 3 / ed. by G. Gregoriadis. Informa Healthcare USA, Inc. 2007. P. 49-55
15. Korb V., Tep K., Escriou V. et. al. Current data on ATP-containing liposomes and potential prospects to enhance cel-lular energy status for hepatic applications // Crit. Rev. Ther. Drug. Carrier. Syst. 2008. V. 25, № 4. P. 305-345.
Review
For citations:
Mukhamadiyarov R.A., Vorontsova N.L., Borisov V.V., Kudryavtseva Yu.A., Juravleva I.Yu. Comparative assessment of hepatoprotective effects of various liposome formulations in experimental venous congestion-induced chronic liver insufficiency. Bulletin of Siberian Medicine. 2012;11(4):130-135. (In Russ.) https://doi.org/10.20538/1682-0363-2012-4-130-135
ISSN 1819-3684 (Online)